ATYR earnings: real EPS beat/miss history, analyst consensus Hold, P/E -0.67. Updated 2026-07-23.
aTyr Pharma (ATYR) Research Hub
aTyr Pharma (ATYR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.4298 USD (-5.62%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.67, market cap 0.05B. This hub links to the full technical, earnings and options research available for ATYR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.4298 USD (-5.62%) |
| 52-week range | 0.425 USD – 0.6998 USD |
| Trend regime | Range |
| 14-day RSI | 39.4 (Bearish) |
| Trailing P/E | -0.67 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for ATYR
Covered Call on ATYR: how it works, illustrative setup around the real 0.4298 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ATYR: how it works, illustrative setup around the real 0.4298 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ATYR: how it works, illustrative setup around the real 0.4298 USD price, max profit/loss, breakeven and when to use it. Educational.
ATYR technical analysis: range, last 0.4298 USD, RSI 39.4, 52w range 0.425 USD–0.6998 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ATYR in?
aTyr Pharma (ATYR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ATYR in an uptrend or downtrend?
As of 2026-09-11, ATYR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ATYR's trailing P/E ratio?
ATYR's trailing P/E is -0.67, with a market cap of 0.05B. See the earnings research page for full valuation detail.